<DOC>
	<DOCNO>NCT00938015</DOCNO>
	<brief_summary>The aim study evaluate data obtain control clinical trial confirm Enbrel use usual clinical practice Belgium accord local reimbursement criterion .</brief_summary>
	<brief_title>Study Evaluating Safety Adherence Treatment With Etanercept Adults With Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<criteria>Active erosive psoriatic arthritis polyarticular type active erosive joint space narrow psoriatic arthritis oligoarticular type At least 18 year old Have fulfil reimbursement criterion Enbrel psoriatic arthritis polyarticular type oligoarticular type Physician decide prescribe Enbrel patient already Enbrel Give write informed consent time inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>postmarketing surveillance</keyword>
	<keyword>Enbrel</keyword>
	<keyword>psoriatic arthritis</keyword>
</DOC>